Cell line · CVCL_1218

FaDu

Cancer cell line, Homo sapiens. Hypopharyngeal squamous cell carcinoma. 129 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. FaDu. Cell lines, record CVCL_1218. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1218

On this page

Cell line

As Cellosaurus gives it.

Name: FaDu
Accession: CVCL_1218
RRID: RRID:CVCL_1218
Synonyms: FaDU, FADU, JHU-SCC-FaDu
Species: Homo sapiens (Human)
Sex: Male
Age at sampling: 56Y
Category: Cancer cell line
Diseases: Hypopharyngeal squamous cell carcinoma (NCIt C4043); Squamous cell carcinoma of the hypopharynx (ORDO Orphanet_494547)
Derived from: Pharynx, hypopharynx (in situ)
Cell type: Epithelial cell
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers129

Paper	Journal	Year	How we know	Source
Regulation of the lncRNA NEAT1 by p53-ΔNp63 crosstalk modulates the DNA damage response and therapeutic efficacy in HNSCC.	Mol Oncol	2026	Its Methods give the RRID and name the line	PubMed
Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor-Resistant Head and Neck Squamous Cell Carcinoma.	Cancer Res Commun	2026	Its Methods give the RRID and name the line	PubMed
SLC15A4 promotes oral cancer progression by regulating TLR9 and activating the JAK/STAT signaling pathway.	Head Face Med	2026	Its Methods give the RRID and name the line	PubMed
ZBP1 Drives CD8+ T cell-mediated anti-tumor immunity in head and neck squamous cell carcinoma.	PLoS Genet	2026	Its Methods give the RRID and name the line	PubMed
An Integrin β6-Targeted Antibody-Drug Conjugate Optimized for Intravesical Delivery to Treat Non-Muscle-Invasive Bladder Cancer.	Mol Cancer Ther	2026	Its Methods give the RRID and name the line	PubMed
TRAPPC4 Promotes GPX4 Stability to Drive Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma.	Cancer Res	2026	Its Methods give the RRID and name the line	PubMed
Hypoxia Induces a Mitotic Survival Advantage After Radiotherapy in Head and Neck Cancer Cells.	Int J Cancer	2026	Its Methods give the RRID and name the line	PubMed
CCL26-Mediated Modulation of Endothelial Secretome by Hypoxia-Induced Tumor-Derived Exosomes Enhances Metastatic Progression in Head and Neck Cancer.	Head Neck	2026	Its Methods give the RRID and name the line	PubMed
Denoising and Baseline Correction of Low-Scan FTIR Spectra: A Benchmark of Deep Learning Models Against Traditional Signal Processing.	Bioengineering (Basel)	2026	Its Methods give the RRID and name the line	PubMed
Fusobacterium nucleatum promotes tumor extravasation and metastasis in head and neck cancer via TLR4/MYB/ESPN axis.	Commun Biol	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 129

See all 129 papers

Relatives13

Relation	Cell line	Accession	Source
Derived from it	EDITGENE FaDu-CopGFP	CVCL_F6BK	Cell lines
Derived from it	EDITGENE FaDu-FLUC	CVCL_F5TZ	Cell lines
Derived from it	ER-Fadu	CVCL_EI27	Cell lines
Derived from it	FaDu 2A3	CVCL_0D71	Cell lines
Derived from it	FaDu ATM KO clone 1B5	CVCL_E8SL	Cell lines
Derived from it	FaDu ATM KO clone 1B6	CVCL_E8SM	Cell lines
Derived from it	FaDu Fat-1	CVCL_E8FQ	Cell lines
Derived from it	FaDu(DD)	CVCL_VP44	Cell lines
Derived from it	FaDu-Luc2	CVCL_A4CG	Cell lines
Derived from it	FaDu-R	CVCL_SA75	Cell lines

1 to 10 of 13

See all 13 relatives

Cell banks8

Cell bank	Catalog number	Source
ATCC	HTB-43	ATCC
BCRC	60214	BCRC
BCRJ	0301	BCRJ
CLS	305033	CLS
DSMZ	ACC-784	DSMZ
EDITGENE	EDC00294	EDITGENE
Hysigen	TCH-C174	Hysigen
KCLB	30043	KCLB

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1218

GET https://conductscience.org/api/cell-lines/v1/CVCL_1218/papers?page=2

API reference For AI assistants